1. Psychoneuroimmunologie und Krebs
   Jochen Hefner et al, 2017, Onkologe CrossRef
2. Triple negative breast cancer: emerging therapeutic modalities and novel combination therapies
   Alice Lee et al, 2017, Cancer Treatment Reviews CrossRef
3. Surgical stress response and promotion of metastasis in colorectal cancer: a complex and heterogeneous process
   Corina Behrenbruch et al, 2018, Clin Exp Metastasis CrossRef
4. Adrenergic Signaling: A Targetable Checkpoint Limiting Development of the Antitumor Immune Response
   Guanxi Qiao et al, 2018, Front. Immunol. CrossRef
5. Visualizing Ligand Binding to a GPCR In Vivo Using NanoBRET
   Diana C. Alcobia et al, 2018, iScience CrossRef
6. Isoproterenol-induced beta-2 adrenergic receptor activation negatively regulates interleukin-2 signaling
   Blanca E. Ruiz-Medina et al, 2018, Biochem. J. CrossRef
7. Perioperative biobehavioral interventions to prevent cancer recurrence through combined inhibition of β-adrenergic and cyclooxygenase 2 signaling
   Itay Ricon et al, 2018, Cancer CrossRef
8. β2-Adrenergic receptor modulates mitochondrial metabolism and disease progression in recurrent/metastatic HPV(+) HNSCC
   Christopher T. Lucido et al, 2018, Oncogenesis CrossRef
9. Propranolol Promotes Glucose Dependence and Synergizes with Dichloroacetate for Anti-Cancer Activity in HNSCC
   Christopher Lucido et al, 2018, Cancers CrossRef
10. The Potential for Cancer Immunotherapy in Targeting Surgery-Induced Natural Killer Cell Dysfunction
    Marisa Market et al, 2018, Cancers CrossRef
11. Beta Blockade as Adjunctive Breast Cancer Therapy: A Review
    Sneha Phadke et al, 2019, Critical Reviews in Oncology/Hematology CrossRef
12. Propranolol inhibits neonatal Nav1.5 activity and invasiveness of MDA-MB-231 breast cancer cells: Effects of combination with ranolazine
    Alice Lee et al, 2019, J Cell Physiol CrossRef
13. Rare, functional, somatic variants in gene families linked to cancer genes: GPCR signaling as a paradigm
    Francesco Raimondi et al, 2019, Oncogene CrossRef
14. The beta adrenergic receptor antagonist propranolol alters mitogenic and apoptotic signaling in late stage breast cancer
    Alexa Montoya et al, 2019, Biomedical Journal CrossRef
15. Label-Free Dynamic Mass Redistribution Reveals Low-Density, Prosurvival α1B-Adrenergic Receptors in Human SW480 Colon Carcinoma Cells
    Dorathy-Ann Harris et al, 2017, J Pharmacol Exp Ther CrossRef
16. Surgical stress and cancer progression: the twisted tango
    Zhiwei Chen et al, 2019, Mol Cancer CrossRef
17. Role of Muscarinic Acetylcholine Receptors in Breast Cancer: Design of Metronomic Chemotherapy
    María E. Sales et al, 2019, CCP CrossRef
18. Spotlight on ROS and β3-Adrenoreceptors Fighting in Cancer Cells
    Maura Calvani et al, 2019, Oxidative Medicine and Cellular Longevity CrossRef
19. null
    Rocío Alejandra Ruiz-Manzano et al, 2019 CrossRef
20. Can stress promote the pathophysiology of brain metastases? A critical review of biobehavioral mechanisms.
    Annina Seiler et al, 2020, Brain Behav Immun CrossRef
21. β2-Adrenergic Signalling Promotes Cell Migration by Upregulating Expression of the Metastasis-Associated Molecule LYPD3
    Michael Gruet et al, 2020, Biology CrossRef
22. Multivariable analysis of association of beta-blocker use and survival in advanced ovarian cancer
    R. Gonzalez et al, 2020, Gynecologic Oncology CrossRef
23. The Autonomic Regulation of Tumor Growth and the Missing Links
    Maricris Bautista et al, 2020, Front. Oncol. CrossRef
24. GRK2-Dependent HuR Phosphorylation Regulates HIF1α Activation under Hypoxia or Adrenergic Stress
    Clara Reglero et al, 2020, Cancers CrossRef
25. Beta-adrenergic receptors are expressed across diverse cancers
    Steven L. Rains et al, 2017, Oncoscience CrossRef
26. Beta-Blockers and Cancer: Where Are We?
    Rita Peixoto et al, 2020, Pharmaceuticals CrossRef
27. The impact of beta blockers on survival outcomes in non-small cell lung cancer patients treated with immune checkpoint inhibitors
    Michael S. Oh et al, 2020, Clinical Lung Cancer CrossRef
28. Stress reduction strategies in breast cancer: review of pharmacologic and non-pharmacologic based strategies
    Rohit Gosain et al, 2020, Semin Immunopathol CrossRef
29. Protein phosphatase 1 in tumorigenesis: Is it worth a closer look?
    Juliana Felgueiras et al, 2020, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
30. Unintended Effects of GPCR-Targeted Drugs on the Cancer Phenotype
    Abigail C. Cornwell et al, 2020, Trends in Pharmacological Sciences CrossRef
31. β-Adrenoceptor Activation in Breast MCF-10A Cells Induces a Pattern of Catecholamine Production Similar to that of Tumorigenic MCF-7 Cells
    Filipa Amaro et al, 2020, IJMS CrossRef
32. Impairment of Hypoxia-Induced CA IX by Beta-Blocker Propranolol—Impact on Progression and Metastatic Potential of Colorectal Cancer Cells
    Monika Barathova et al, 2020, IJMS CrossRef
33. Propranolol: What is BLOCKing Its Clinical Investigation in Breast Cancer?
    Anne H. Blaes et al, 2020, Clin Cancer Res CrossRef
34. Drug combination and repurposing for cancer therapy: the example of breast cancer
    Ana Salomé Correia et al, 2021, Heliyon CrossRef
35. Beta-blockers in early-stage breast cancer: a systematic review and meta-analysis
    R. Caparica et al, 2021, ESMO Open CrossRef
36. Neuroimmune Regulation of Surgery-Associated Metastases
    Michael R. Shurin et al, 2021, Cells CrossRef
37. Perioperative use of β-blockers in oncological patients
    P. P. Sorochan et al, 2021, УРОЖ CrossRef
38. Association Between Antihypertensive Medication Use and Breast Cancer: A Systematic Review and Meta-Analysis
    Yuxiu Xie et al, 2021, Front. Pharmacol. CrossRef
39. Neurobiology of Cancer: Introduction of New Drugs in the Treatment and Prevention of Cancer
    Boris Mravec, 2021, IJMS CrossRef
40. Role of α- and β-adrenergic signaling in phenotypic targeting: significance in benign and malignant urologic disease
    M. Archer et al, 2021, Cell Commun Signal CrossRef
41. Antihypertensive medications and risks of recurrence and mortality in luminal, triple-negative, and HER2-overexpressing breast cancer
    Nicole C. Lorona et al, 2021, Cancer Causes Control CrossRef
42. Stress and cancer: mechanisms, significance and future directions
    Anabel Eckerling et al, 2021, Nat Rev Cancer CrossRef
43. The Risk of Antihypertensive Drug among Breast Cancer Patient: A Systematic Review and Meta-analysis
    Sinta Wiranata et al, 2021, Open Access Maced J Med Sci CrossRef
44. null
    Claire Magnon, 2021 CrossRef
45. The molecular mechanism of chronic stress affecting the occurrence and development of breast cancer and potential drug therapy
    Hui-min Liu et al, 2022, Translational Oncology CrossRef
46. Contribution of adrenergic mechanisms for the stress‐induced breast cancer carcinogenesis
    Dany Silva et al, 2022, Journal Cellular Physiology CrossRef
47. Stress in Metastatic Breast Cancer: To the Bone and Beyond.
    Carmen Jeronimo, 0 CrossRef
48. Beta 2-Adrenergic Receptor in Circulating Cancer-Associated Cells Predicts for Increases in Stromal Macrophages in Circulation and Patient Survival in Metastatic Breast Cancer
    Kirby P. Gardner et al, 2022, IJMS CrossRef
49. Chronic restraint stress promotes gastric epithelial malignant transformation by activating the Akt/p53 signaling pathway via ADRB2
    Chuanju Zong et al, 2022, Oncol Lett CrossRef
50. The Nervous System as a Regulator of Cancer Hallmarks: Insights into Therapeutic Implications
    Karla V. Torres-Juárez et al, 2022, Cancers CrossRef
51. Crosstalk between the peripheral nervous system and breast cancer influences tumor progression
    Jianming Hu et al, 2022, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
52. null
    Anand Krishnan, 2022 CrossRef
53. Does Primary Tumor Resection Induce Accelerated Metastasis in Breast Cancer? A Review
    Yile Jiao et al, 2023, Journal of Surgical Research CrossRef
54. Influence of Perioperative Anesthesia on Cancer Recurrence: from Basic Science to Clinical Practice
    Sun-hui Xia et al, 2022, Curr Oncol Rep CrossRef
55. Breast cancer and neurotransmitters: emerging insights on mechanisms and therapeutic directions
    Priya Jayachandran et al, 2023, Oncogene CrossRef
56. Surgery in the Setting of Metastatic Breast Cancer
    Jennifer K. Plichta et al, 2023, Curr Breast Cancer Rep CrossRef
57. Neuroepithelial Interactions in Cancer
    Gustavo Ayala, 2023, Annu. Rev. Pathol. Mech. Dis. CrossRef
58. ß-Adrenoreceptors in Human Cancers
    Zoltan Kraboth et al, 2023, IJMS CrossRef
59. Using administrative healthcare data to evaluate drug repurposing opportunities for cancer: the possibility of using beta-blockers to treat breast cancer
    George S. Q. Tan et al, 2023, Front. Pharmacol. CrossRef
60. Role of stress in the pathogenesis of cancer (Review)
    Ioannis Lempesis et al, 2023, Int J Oncol CrossRef
61. null
    Rosario Amato et al, 2023 CrossRef
62. A brain-tumor neural circuit controls breast cancer progression in mice
    Si-Yi Xiong et al, 2023 CrossRef
63. Beta-blocker adjunct therapy as a prospective anti-metastatic with cardio-oncologic regulation
    Sachin G Nair et al, 2024, Clin Exp Metastasis CrossRef
64. β2-Adrenoceptor Activation Favor Acquisition of Tumorigenic Properties in Non-Tumorigenic MCF-10A Breast Epithelial Cells
    Dany Silva et al, 2024, Cells CrossRef
65. Propranolol inhibits EMT and metastasis in breast cancer through miR-499-5p-mediated Sox6
    Bo Zheng et al, 2024, J Cancer Res Clin Oncol CrossRef